Rimegepant Plus Toripalimab in Advanced Urothelial Carcinoma After Failure of Standard Therapy

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Rimegepant Plus Toripalimab in Advanced Urothelial Carcinoma After Failure of Standard Therapy	Advanced Urothelial Carcinoma	Recruiting	Phase 1	2026-09-22		NCT07835035

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	294

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Beijing Huanxing Cancer Hospital	Beijing	China	1
Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College	Beijing	China	5

Clinical trials